IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech

Displaying 441 - 460 of 2007 stories.
May 8, 2013
Renewable chemicals maker BioAmber has lowered the price range for its proposed initial public offering, saying in an SEC filing that it is now looking to raise $88 million by...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/BioAmber-cuts-IPO-share-price_51855.html
May 7, 2013
DuPont Tate & Lyle Bio Products (DuPont Tate & Lyle), a joint venture between DuPont and agrobusiness firm Tate & Lyle, says it has partnered with preservatives...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/DuPont-Tate-and-Lyle-RML-develop-biobased-personal-care-ingredients_51819.html
May 7, 2013
BASF says it has begun a project to install new gas-fired boilers to generate steam at its Hannibal, MO, site as part of its plan to spend, on average, €300 million ($390 million)...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/BASF-invests-in-Missouri-crop-protection-site_51818.html
May 7, 2013
Biobased plastics firm Cereplast (El Segundo, CA) says it will relocate its corporate headquarters to Seymour, IN, to save costs and move its European headquarters to Milan in order to...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Cereplast-announces-restructuring_51817.html
May 7, 2013
Dow AgroSciences says US regulatory authorities have approved a new insecticidal active ingredient, sulfoxaflor, to be marketed in the United States. Sulfoxaflor belongs to a novel...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Dow-insecticide-receives-US-regulatory-approval_51812.html
May 7, 2013
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel), recorded a 6.5% fall in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-7-May_51808.html
May 3, 2013
Cambrex (East Rutherford, NJ) reports a 58.6% increase in net profits for the first quarter, ended 31 March, compared with the year-ago period, to $11.16 million. First-quarter sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-rise-in-profits-and-sales_51752.html
May 3, 2013
Bayer CropScience is changing its management structure following the retirement at the end of May of Rüdiger Scheitza, head of strategy and business management (SBM) and...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Bayer-CropScience-changes-management-structure_51744.html
May 3, 2013
Vertellus Specialties (Indianapolis) says that its facility at Antwerp has completed capital and other upgrades for the manufacture of niacin, or nicotinic acid, for pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Vertellus-upgrades-Belgium-facility-for-API-niacin-manufacture_51741.html
May 2, 2013
Chemtura today reported a first-quarter net loss from continuing operations of $22 million, compared with a profit of $22 million in the year-ago period. Net sales declined 1.9%...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Chemtura-earnings-fall-short-of-estimates-on-soft-demand_51715.html
May 2, 2013
DSM's core net profit fell 13.4%, to €129 million ($170 million) during the first quarter of 2013, compared with the same period last year when it stood at €149 million, the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSMs-net-profit-falls-13-percent-in-the-first-quarter-as-performance-materials-sales-decline_51661.html
April 30, 2013
FMC today reported first-quarter net income up 10% year-on-year (YOY), to $130.9 million, on sales up 5%, to $990.2 million. Excluding special charges, adjusted earnings totaled...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/FMC-earnings-rise-on-solid-ag-biopolymers-results_51618.html
April 30, 2013
Biobased isobutanol firm Gevo (Englewood, CO) reported a net loss of $18.4 million (45 cts/share) for its fiscal first-quarter ended 31 March, compared with a net loss of $19.3 million...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Gevo-posts-net-loss-on-track-for-Luverne-restart-in-2013_51619.html
April 30, 2013
Biobased farnesene producer Amyris (Emeryville, CA) reported a net loss of $32.3 million for its fiscal first-quarter ended 31 March compared with a net loss of $94.9 million in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Amyris-sales-slide-73-percent-on-shelving-of-biofuels_51616.html
April 30, 2013
Lonza results in line with expectations Lonza, in its business update announcement for the first quarter of 2013, says that its business performance was solid and in line with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-30-April_51592.html
April 29, 2013
The European Commission, following a vote by EU member states today, will proceed with a plan to restrict the use of three neonicotinoids used as insecticides on a variety of crops...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/European-Commission-proceeds-with-plan-to-restrict-the-use-of-neonicotinoids_51559.html
April 29, 2013
The active pharmaceutical ingredient (API) business of Covidien (Dublin) report an 11.4% rise in sales in the company’s second quarter, ended 29 March, compared with the year-ago...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Covidien-reports-rise-in-API-sales_51560.html
April 29, 2013
Pharmaceutical company Ipsen (Paris) says that it expects a supply interruption for its product Increlex, a treatment for growth failure in children, as a result of the manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ipsen-expects-Increlex-supply-interruption-due-to-issues-at-Lonza-Hopkinton-site_51556.html
April 26, 2013
Chemical production in Argentina was up 2.6% during the first quarter of this year compared with the same quarter in 2012, according to figures released by state statistics office...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Argentinas-chemicals-output-up-2-6-percent-during-the-first-quarter_51529.html
April 23, 2013
Monsanto says it will invest $400 million to expand its R&D capabilities at its St. Louis Chesterfield Village Research Center, add 36 new greenhouses and 675 jobs over the...
http://www.chemweek.com/markets/fine_chemicals_biotech/seeds_and_traits/Monsanto-investing-$400-million-to-expand-St-Louis-research-campus_51374.html
Pages: « Previous  14 15 16 17 18 19 20 21 22 [23] 24 25 26 27 28 29 30 31 32 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa